Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients
- 8 April 2005
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 19 (6) , 625-627
- https://doi.org/10.1097/01.aids.0000163940.85940.03
Abstract
We prospectively studied the initial results of 6 months of generic efavirenz-based therapy on the plasma viral load in 40 patients at YRG Centre for AIDS Research and Education, a tertiary HIV referral centre in southern India. The median baseline plasma viral load was 259 000 copies/ml and at 6 months 95% of patients had plasma viral loads less than 400 copies/ml. The data support the use of generic non-nucleoside reverse transcriptase inhibitor-based regimens in resource-limited settings.Keywords
This publication has 7 references indexed in Scilit:
- Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trialThe Lancet, 2004
- Comparison of Generic Zidovudine + Lamivudine (Cipla, Duovir) and the GlaxoSmithKline Brand (Combivir) TabletsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyThe Lancet, 2004
- Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 InfectionNew England Journal of Medicine, 2003
- The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south IndiaAIDS, 2003
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitorsAIDS, 1999